Value through Innovation16 January 2013

Hypertension News and Information

This section includes information and resources about Hypertension for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

Hypertension Press Releases

back12 3 next

29.04.2012	Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals - For Non-US and Non-UK Healthcare Media Only
17.06.2011	New data confirm superior blood pressure reductions in diabetic patients treated with TWYNSTA® compared to amlodipine alone - For NON-US and NON-UK Healthcare Media Only
12.10.2010	European Medicines Agency approves TWYNSTA® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours - For non-US and non-UK Healthcare Media Only
31.08.2010	Combination therapy of telmisartan and amlodipine provides significantly better blood pressure lowering than either agent alone - For non-US and non-UK Healthcare Media only
26.07.2010	European Committee for Medicinal Products for Human Use (CHMP) adopts Positive Opinion for TWYNSTA®, Boehringer Ingelheim’s new single pill combination hypertension treatment - For non-US and non-UK Healthcare Media